Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

SeraCare: Human genomic, multiple allele controls for genetic testing
November 2008
SHARING OPTIONS:

SeraCare Life Sciences Inc. announces the introduction of ACCURUN quality controls for warfarin sensitivity and thrombophilia testing, marking the anticipated launch of the company's genetic controls business. These independent controls are the first genomic controls characterized for multiple alleles of multiple genes in ready-to-use, single-use format and are designed to improve accuracy and efficiency in laboratories conducting genetic testing for warfarin sensitivity and thrombophilia. ACCURUN 601 includes the most relevant alleles for warfarin sensitivity and is the only control kit in the market configured as a single package to control for both CYP2C9 and VKORC1 screening, covering two allelic mutations for the CYP2C9 gene and six mutations for the VKORC1 gene.  ACCURUN 610 is a single package, multi-analyte control for genetic screening of both the 677C>T mutation and the 1298A>C mutation in the methylenetetrahydrofolate reductase (MTHFR) gene.

 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.